cerrar
Tagged with biotech

UK Pharma News Roundup May 2020
Below we highlight some recent developments in pharma and healthcare in the UK, including drug shortages in British intensive care units (ICUs),…

Chinese Biotechs’ Domestic Pricing Strategies
Alphamab Oncology and I-Mab Biopharma, two of China’s fastest-growing biotech firms, both bolstered by recent successful IPOs, are increasingly…

Chae-Ok Yun – Founder, CEO & CTO, GeneMedicine
Founder, CEO and CTO Dr Chae-Ok Yun introduces GeneMedicine, a pioneer of the oncolytic virus approach in gene therapy. Dr Yun outlines the…

Xu Ting – Founder, Chairman & CEO, Alphamab Oncology,…
PharmaBoardroom caught up with Alphamab Oncology’s founder, chairman and CEO Dr Xu Ting again 16 months after our last interview to hear about their…

Jielun Zhu – CFO, I-Mab Biopharma, China
I-Mab Biopharma CFO Jielun Zhu recaps the exciting milestones for the company over the past year since our last interview in May 2019, including most…

Dirk Reyn – President, Flanders.bio, Belgium
Dirk Reyn of Flanders.bio highlights what the Flanders region has to offer the life sciences and biotech industries in terms of research…

5 Cell & Gene Companies to Watch in South Korea
South Korea is the 12th largest healthcare market globally with a market size of around USD 20 billion in 2019. With the government’s plans to…

Jingsong Wang – Chairman & CEO, Harbour BioMed, China
PharmaBoardroom caught up with Dr Jingsong Wang, chairman & CEO of Harbour BioMed to discuss the exciting clinical and commercial milestones of…

Miguel Forte – CEO, Bone Therapeutics, Belgium
Miguel Forte, CEO of Bone Therapeutics, walks through his journey leading the promising Belgian biotech company. He also shares with his view of the…

Eric Halioua – President & CEO, PDC*Line Pharma,…
PDC*Line Pharma’s Eric Halioua introduces the Belgian immuno-oncology biotech, its clinical-stage assets, the impact of the firm’s collaboration…

China’s Clover Biopharmaceuticals Partners with GSK on…
Chinese biotech Clover Biopharmaceuticals may have flown under the radar thus far but it has stepped into the global limelight recently by partnering…

China: A New Decade
2019 was a landmark year for the Chinese healthcare industry.* Since the publication of the ‘Healthy China 2030’ blueprint in 2016 by the Chinese…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here